(Q39029837)

English

Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir

scientific article published on September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giovanni Guaraldi

15

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Eugenia Quiros-Roldan

14

object named as

Eugenia Quiros-Roldan

0 references

object named as

Paolo Maggi

12

0 references

author name string

Daria Gotti

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Bruno Mario Cesana

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Laura Albini

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Alessandra Calabresi

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ilaria Izzo

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Emanuele Focà

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Davide Motta

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Rita Bellagamba

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Rita Fezza

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Pasquale Narciso

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Laura Sighinolfi

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Nigritella Brianese

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Carol Torti

16

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

1 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

245-255

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Antiinflammatory properties of HDL.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Role of lipid and lipoprotein profiles in risk assessment and therapy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strate

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study).

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Evidence that triglycerides are an independent coronary heart disease risk factor

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1305-245

21 January 2018

Identifiers

10.1310/HCT1305-245

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39029837&oldid=2153050808"